XTL Provides Update on HepeX-B Program
July 19, 2006 19:00 ET
|
XTL Biopharmaceuticals
NEW YORK, July 19, 2006 (PRIMEZONE) -- XTL Biopharmaceuticals, Ltd. (Nasdaq:XTLB) (LSE:XTL) (Tel Aviv:XTL) provided today an update on HepeX-B -- a drug candidate for the prevention of re-infection...
XTL Biopharmaceuticals Ltd. Provides Update to 2005 Annual Report on Form 20-F
June 02, 2006 16:30 ET
|
XTL Biopharmaceuticals
NEW YORK, June 2, 2006 (PRIMEZONE) -- XTL Biopharmaceuticals Ltd., (Nasdaq:XTLB) (LSE:XTL) (TASE:XTL) ("XTL"), a biotechnology company focused on the acquisition, development and commercialization of...